NovoCure (NVCR) EPS (Basic) Growth (1y) (2015 - 2026)
NovoCure (NVCR) EPS (Basic) Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.52 Bn | 175.22 Bn | 6.27 Bn | -18.87% |
| 2 | Stryker | 128.96 Bn | 126.09 Bn | 3.81 Bn | 13.56% |
| 3 | Medtronic | 107.99 Bn | 98.77 Bn | 6.41 Bn | 18.90% |
| 4 | Boston Scientific | 67.76 Bn | 66.31 Bn | 3.61 Bn | 97.93% |
| 5 | Edwards Lifesciences | 48.09 Bn | 44.41 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn | 92.23% |
| 7 | GE HealthCare Technologies | 27.89 Bn | 25.61 Bn | 1.98 Bn | -29.95% |
| 8 | Smith & Nephew | 27.02 Bn | 26.45 Bn | - | - |
| 9 | Koninklijke Philips | 23.98 Bn | 20.86 Bn | 2.07 Bn | 114.97% |
| 10 | NovoCure | 1.98 Bn | 1.54 Bn | 142.48 Mn | 62.48% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 62.48% |
| Mar 31, 2026 | -100.26% |
| Dec 31, 2025 | 64.05% |
| Sep 30, 2025 | -17.93% |
| Jun 30, 2025 | -16.09% |
| Mar 31, 2025 | 13.88% |
| Dec 31, 2024 | -38.15% |
| Sep 30, 2024 | 39.07% |
| Jun 30, 2024 | 42.64% |
| Mar 31, 2024 | 28.04% |
| Dec 31, 2023 | -24.15% |
| Sep 30, 2023 | -82.91% |
| Jun 30, 2023 | -135.42% |
| Mar 31, 2023 | -1,025.83% |
| Dec 31, 2022 | -39.34% |
| Sep 30, 2022 | -100.27% |
| Jun 30, 2022 | -62.19% |
| Mar 31, 2022 | -10.90% |
| Dec 31, 2021 | -625.07% |
| Sep 30, 2021 | -237.96% |